Latest Breaking News On - Marka mcpartland - Page 1 : comparemela.com

VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders, today announced that Shawn Singh, VistaGen’s Chief Executive Officer, will participate in the following investor conferences in March: Maxim Group and M-Vest’s Inaugural Emerging Growth Virtual Conference Dates:   Format: Website:   Date: Format:   About VistaGen VistaGen Therapeutics is a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen’s three drug candidates has a differentiated poten

Jason mccarthyShawn singhMarka mcpartlandMaxim groupVistagen therapeutics incCompany contactResearch analystVistagen therapeuticsChief executive officerInaugural emerging growth virtualGen therapeuticsஜேசன் ம்க்கார்தீஷான் சிங்மார்க்கா மக்பார்ட்‌ல்யாஂட்மாக்சிம் குழுநிறுவனம் தொடர்பு